We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov
ClinicalTrials.gov Menu

Molecular Analysis Of Bladder Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00871754
Recruitment Status : Active, not recruiting
First Posted : March 30, 2009
Last Update Posted : March 8, 2017
Sponsor:
Information provided by (Responsible Party):

Study Description
Brief Summary:
This is a laboratory study where the investigators hope to look at chromosomal events implicated in bladder cancer.

Condition or disease
Bladder Cancer Bladder Neoplasms

Study Design

Study Type : Observational
Estimated Enrollment : 5000 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Molecular Analysis Of Bladder Cancer
Study Start Date : April 1988
Estimated Primary Completion Date : December 2020
Estimated Study Completion Date : December 2020

Resource links provided by the National Library of Medicine

MedlinePlus related topics: Bladder Cancer
U.S. FDA Resources

Groups and Cohorts


Outcome Measures

Biospecimen Retention:   Samples With DNA
Blood

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Ages Eligible for Study:   18 Years and older   (Adult, Senior)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Non-Probability Sample
Study Population
patient's undergoing removal of a malignant bladder tumor
Criteria

Inclusion Criteria:

  • Bladder cancer
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00871754


Locations
United States, Massachusetts
Lahey Clinic
Burlington, Massachusetts, United States, 01805
Sponsors and Collaborators
Lahey Clinic
Investigators
Principal Investigator: Kim Reiger-Christ, PhD Lahey Clinic
More Information

Responsible Party: Linda Topjian, study coordinator, Lahey Clinic
ClinicalTrials.gov Identifier: NCT00871754     History of Changes
Other Study ID Numbers: 88-009A
First Posted: March 30, 2009    Key Record Dates
Last Update Posted: March 8, 2017
Last Verified: March 2017

Keywords provided by Linda Topjian, Lahey Clinic:
Bladder Cancer
Cancer, bladder
Urinary Bladder Cancer

Additional relevant MeSH terms:
Urinary Bladder Neoplasms
Urologic Neoplasms
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Urinary Bladder Diseases
Urologic Diseases